triazoles has been researched along with lignans in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, CV; Barbosa-Filho, JM; Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; Moreira, S; Thomas, G; Tibiriçá, EV | 1 |
| Aimbire, F; Cailleaux, S; Cordeiro, RS; Lopes-Martins, RA; Tibiriçá, E | 1 |
| Assis, EF; Barbosa-Filho, JM; Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; Jesus-Morais, CM; Lima, WT; Silva, ZL | 1 |
| Araújo, CV; Barbosa-Filho, JM; Cordeiro, RS; Tibiriçá, E | 1 |
| Burgos, RA; Folch, H; Hancke, JL; Hermosilla, R; Hidalgo, MA; Matthei, SM | 1 |
| Chiu, PY; Ko, KM; Mak, DH; Poon, MK | 1 |
| Appukkuttan, P; Beryozkina, T; Mont, N; Van der Eycken, E | 1 |
| Calixto, JB; Kassuya, CA; Marotta, DM; Menezes-de-Lima, O; Rehder, VL; Silvestre, A | 1 |
| Cafici, L; Canonico, PL; Galli, U; Genazzani, AA; Imperio, D; Pagliai, F; Pirali, T; Sorba, G; Tron, GC | 1 |
| Gao, P; Hu, Z; Hu, ZN; Wang, JR; Wu, WJ; Zhang, JW | 1 |
| Andrews, C; Clark, K; Edge, SB; Fetterly, G; Hicks, DG; Kulkarni, S; McCann, SE; Morrison, CD; Thompson, LU; Wilton, J | 1 |
| Jadav, SS; Reddy, CR; Sasane, N; Subbarao, M; Supriya, B; Ummanni, R; Valleti, RR; Vijaykumar, J | 1 |
| Bernardes, LSC; da Rosa, R; de Melo, EB; de Moraes, MH; Paula, FR; Schenkel, EP; Steindel, M; Zimmermann, LA | 1 |
| Arruda, CCP; Barbosa, NV; Baroni, ACM; Carvalho, DB; das Neves, AR; Honorato, AM; Kadri, MCT; Kato, MJ; Moslaves, IS; Trefzger, OS; Yoshida, NC | 1 |
| Bento Carvalho, D; Cardozo Pinto de Arruda, C; da Silva Calabrese, K; da Silva Freitas de Souza, C; de Jesus Hardoim, D; de Morais Baroni, AC; Nosomi Taniwaki, N; Silva Rizk, Y; Zaverucha do Valle, T | 1 |
| Baroni, ACM; Carvalho, DB; Carvalho, MG; Cassamale, TB; das Neves, AR; Duarte, RCF; Felipe, JL; Lourenço, LD; Toffoli-Kadri, MC | 1 |
1 trial(s) available for triazoles and lignans
| Article | Year |
|---|---|
A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Estrogen Receptor beta; Female; Flax; Gonadal Steroid Hormones; Humans; Lignans; Linear Models; Middle Aged; Nitriles; Pilot Projects; Treatment Outcome; Triazoles; Young Adult | 2014 |
15 other study(ies) available for triazoles and lignans
| Article | Year |
|---|---|
Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: in vivo pharmacological studies.
Topics: Animals; Antihypertensive Agents; Azepines; Blood Platelets; Female; Furans; Heart Rate; Leukocytes; Lignans; Male; Plants; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Triazoles | 1995 |
Involvement of platelet-activating factor in the modulation of vascular tone in the isolated perfused rabbit kidney.
Topics: Animals; Azepines; Dinoprost; Enzyme Inhibitors; Female; Furans; In Vitro Techniques; Kidney; Lignans; Male; Muscle Tonus; Muscle, Smooth, Vascular; Norepinephrine; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors; Quinacrine; Rabbits; Renal Circulation; Triazoles; Vasoconstrictor Agents | 1999 |
Yangambin, a lignan obtained from Ocotea duckei, differentiates putative PAF receptor subtypes in the gastrointestinal tract of rats.
Topics: Animals; Azepines; Digestive System; Female; Furans; In Vitro Techniques; Lauraceae; Lignans; Male; Mice; Mice, Inbred C3H; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 2000 |
Protective effects of yangambin on cardiovascular hyporeactivity to catecholamines in rats with endotoxin-induced shock.
Topics: Animals; Azepines; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Drug Interactions; Furans; Heart Rate; Lignans; Lipopolysaccharides; Male; Norepinephrine; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Cardiogenic; Shock, Septic; Triazoles; Vasoconstrictor Agents | 2001 |
Determination of specific receptor sites for platelet activating factor in bovine neutrophils.
Topics: Animals; Azepines; Base Sequence; Blotting, Western; Cattle; Cyclooctanes; Diterpenes; DNA Primers; DNA, Complementary; Enzyme-Linked Immunosorbent Assay; Ginkgolides; HL-60 Cells; Humans; Kinetics; Lactones; Lignans; Molecular Sequence Data; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Polycyclic Compounds; Radioligand Assay; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Triazoles; Tritium | 2004 |
Role of cytochrome P-450 in schisandrin B-induced antioxidant and heat shock responses in mouse liver.
Topics: Administration, Oral; Animals; Antioxidants; Cyclooctanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Heat-Shock Response; Lignans; Liver; Mice; Mice, Inbred BALB C; Microsomes, Liver; Mitochondria, Liver; NADP; Oxidative Stress; Polycyclic Compounds; Schisandraceae; Triazoles | 2005 |
Microwave-enhanced synthesis of new (-)-steganacin and (-)-steganone aza analogues.
Topics: 4-Butyrolactone; Aza Compounds; Cyclization; Lignans; Microwaves; Molecular Structure; Stereoisomerism; Triazoles | 2006 |
Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
Topics: Analgesics; Animals; Anisoles; Anti-Inflammatory Agents; Azepines; Binding, Competitive; Carrageenan; Cerebral Cortex; Dioxoles; Inflammation; Lignans; Male; Mice; Pain Measurement; Pain Threshold; Peroxidase; Phyllanthus; Plant Extracts; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pleurisy; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Tetrahydronaphthalenes; Time Factors; Triazoles | 2006 |
Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry.
Topics: 4-Butyrolactone; Antineoplastic Agents; Catalysis; Cell Line, Tumor; Humans; Lactones; Lignans; Molecular Conformation; Podophyllotoxin; Ruthenium; Triazoles; Tubulin | 2007 |
Synthesis and larvicidal activity against Culex pipiens pallens of new triazole derivatives of phrymarolin from Phryma leptostachya L.
Topics: Animals; Benzodioxoles; Culex; Insecticides; Larva; Lignans; Magnetic Resonance Spectroscopy; Magnoliopsida; Molecular Conformation; Plant Extracts; Spectrometry, Mass, Electrospray Ionization; Triazoles | 2013 |
One-Pot Synthesis of Triazolo-Heterolignans: Biological Evaluation and Molecular Docking Studies as Tubulin Inhibitors.
Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lignans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Triazoles; Tubulin; Tumor Cells, Cultured | 2018 |
Synthesis and SAR of new isoxazole-triazole bis-heterocyclic compounds as analogues of natural lignans with antiparasitic activity.
Topics: Antiprotozoal Agents; Carbon-13 Magnetic Resonance Spectroscopy; Drug Evaluation, Preclinical; Heterocyclic Compounds; Humans; Isoxazoles; Leishmania; Lignans; NADH, NADPH Oxidoreductases; Proton Magnetic Resonance Spectroscopy; Spectrophotometry, Infrared; Structure-Activity Relationship; THP-1 Cells; Triazoles; Trypanosoma cruzi | 2018 |
Effect of isoxazole derivatives of tetrahydrofuran neolignans on intracellular amastigotes of Leishmania (Leishmania) amazonensis: A structure-activity relationship comparative study with triazole-neolignan-based compounds.
Topics: Animals; Antiprotozoal Agents; Drug Design; Female; Furans; Inhibitory Concentration 50; Isoxazoles; Leishmania; Life Cycle Stages; Lignans; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nitric Oxide; Structure-Activity Relationship; Triazoles | 2019 |
A Triazole Hybrid of Neolignans as a Potential Antileishmanial Agent by Triggering Mitochondrial Dysfunction.
Topics: Animals; Antiprotozoal Agents; Leishmania mexicana; Lignans; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mitochondria; Triazoles | 2019 |
Anti-inflammatory, ulcerogenic and platelet activation evaluation of novel 1,4-diaryl-1,2,3-triazole neolignan-celecoxib hybrids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Carrageenan; Celecoxib; Dose-Response Relationship, Drug; Edema; Lignans; Male; Mice; Molecular Structure; Peritonitis; Platelet Activation; Platelet Aggregation Inhibitors; Rats; Structure-Activity Relationship; Triazoles; Ulcer | 2022 |